Contrast-enhanced CT and liver surface nodularity for the diagnosis of porto-sinusoidal vascular disorder: A case-control study

Background and aims: Porto-sinusoidal vascular disorder (PSVD) is a rare and commonly overlooked cause of portal hypertension. The interest of CT analysis, including quantification of liver surface nodularity (LSN) for PSVD diagnosis has not been established. This study aimed at assessing the performance of LSN and CT features for a PSVD diagnosis in patients with signs of portal hypertension.

Approach and results: This retrospective case-control study included a learning cohort consisting of 50 patients with histologically proven PSVD, according to VALDIG criteria, and 100 control patients with histologically proven cirrhosis, matched on ascites. All patients and controls had at least one sign of portal hypertension and CT available within 1 year of liver biopsy. Principal component analysis of CT features separated patients with PSVD from patients with cirrhosis. Patients with PSVD had lower median LSN than those with cirrhosis (2.4 vs. 3.1, p < 0.001). Multivariate analysis identified LSN < 2.5 and normal-sized or enlarged segment IV as independently associated with PSVD. Combination of these two features had a specificity of 90% for PSVD and a diagnostic accuracy of 84%. Even better results were obtained in an independent multicenter validation cohort including 53 patients with PSVD and 106 control patients with cirrhosis (specificity 94%, diagnostic accuracy 87%).

Conclusions: This study that included a total of 103 patients with PSVD and 206 patients with cirrhosis demonstrates that LSN < 2.5 combined with normal-sized or enlarged segment IV strongly suggests PSVD in patients with signs of portal hypertension.

[:]

Other publications

EASL Clinical Practice Guidelines on vascular diseases of the liver

J Hepatol.

12 Nov 2025

Authors :

Pierre-Emmanuel Rautou,

Lucile Moga,

Virginia Hernandez-Gea,

Walter Ageno,

Sarwa Darwish Murad,

Juan-Carlos Garcia-Pagan,

Maria Guido,

Valérie McLin,

Dhiraj Tripathi,

Valérie Vilgrain,

European Association for the Study of the Liver,

Find out more

Liver biopsy quality criteria to exclude cirrhosis in case of suspicion of porto-sinusoidal vascular disorder

JHEP Reports

09 Nov 2025

Authors :

Chloé de Broucker,

Valérie Paradis,

Maria Luisa Botero,

Miguel Albuquerque,

Audrey Payancé,

Aurélie Plessier,

Laure Elkrief,

François Durand,

Sophie Hillaire,

Paul-Emile Zafar,

Juan Carlos Garcia Pagan,

Pierre-Emmanuel Rautou,

Find out more

JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm

[:fr]Nature Communications.[:]

03 Nov 2022

Authors :

[:fr]Rida Al-Rifai[:],

[:fr]Marie Vandestienne[:],

[:fr]Jean-Rémi Lavillegrand[:],

[:fr]Tristan Mirault[:],

[:fr]Julie Cornebise[:],

Johanne Poisson,

[:fr]Ludivine Laurans[:],

[:fr]Bruno Esposito[:],

[:fr]Chloé James[:],

[:fr]Olivier Mansier[:],

[:fr]Pierre Hirsch[:],

[:fr]Fabrizia Favale[:],

[:fr]Rayan Braik[:],

[:fr]Camille Knosp[:],

[:fr]Jose Vilar[:],

[:fr]Giuseppe Rizzo[:],

[:fr]Alma Zernecke[:],

[:fr]Antoine-Emmanuel Saliba[:],

[:fr]Alain Tedgui[:],

[:fr]Maxime Lacroix[:],

[:fr]Lionel Arrive[:],

[:fr]Ziad Mallat[:],

[:fr]Soraya Taleb[:],

[:fr]Marc Diedisheim[:],

[:fr]Clément Cochain[:],

Pierre-Emmanuel Rautou,

[:fr]Hafid Ait-Oufella[:],

Find out more

Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures

[:fr]J Thromb Haemost.[:]

21 Sep 2022

Authors :

[:fr]Julien Bissonnette[:],

[:fr]Alix Riescher-Tuczkiewicz[:],

[:fr]Elia Gigante[:],

[:fr]Carole Bourdin[:],

[:fr]Larbi Boudaoud[:],

[:fr]Heithem Soliman[:],

François Durand,

Maxime Ronot,

Dominique Valla,

Valérie Vilgrain,

[:fr]Emmanuelle de Raucourt[:],

Pierre-Emmanuel Rautou,

Find out more